Yoshiji, Hitoshi
Nagoshi, Sumiko
Akahane, Takemi
Asaoka, Yoshinari
Ueno, Yoshiyuki
Ogawa, Koji
Kawaguchi, Takumi
Kurosaki, Masayuki
Sakaida, Isao
Shimizu, Masahito
Taniai, Makiko
Terai, Shuji
Nishikawa, Hiroki
Hiasa, Yoichi
Hidaka, Hisashi
Miwa, Hiroto
Chayama, Kazuaki
Enomoto, Nobuyuki
Shimosegawa, Tooru
Takehara, Tetsuo
Koike, Kazuhiko
Article History
Received: 25 February 2021
Accepted: 25 February 2021
First Online: 7 July 2021
Declarations
:
: Any financial relationship with enterprises, businesses or academic institutions in the subject matter or materials discussed in the manuscript are listed as follows: (1) those from which the enterprises and for-profit organizations received remuneration paid as patent royalties; SRL, (2) those from which the authors, the spouse, partner or immediate relatives of the authors have received individually any income, honoraria or any other type of renumeration; Abbvie, Otsuka Pharmaceutical, Gilead Sciences, Sumitomo Dainippon Pharma, MSD, Eisai, EA Pharma, Bristol Myers Squibb, Mitsubishi Tanabe Pharma, Bayer Yakuhin, ASKA Pharmaceutical, Daiichi Sankyo, Takeda Pharmaceutical, Taiho Pharmaceutical, Chugai Pharmaceutical, (3) those from which the academic institutions of the authors received support (commercial/academic cooperation); Abbvie, Otsuka Pharmaceutical, EA Pharma, Gilead Sciences, Sumitomo Dainippon Pharma, Takeda Pharmaceutical, Bristol Myers Squibb, Eisai, MSD, Nippon Kayaku, Ono Pharmaceutical, Teijin Pharma, Novartis Pharma, ASKA Pharmaceutical, Astellas Pharmaceutical, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Chugai Pharmaceutical, Toray, Mochida Pharmaceutical, Interstem, Rohto Pharmaceutical, Towa Pharmaceutical, Nihon Pharmaceutical, Janssen Pharmaceutical, MIC Medical, Kowa, and 4)those from which the authors have received individually endowed chair;Shibuya Corporation.